Maven Biotechnologies

About:

Maven Biotechnologies develops Polaron and LFIRE, internal reflection ellipsometry analysis systems for microplates and slide disposables.

Website: http://www.mavenbiotech.com

Top Investors: National Institutes of Health

Description:

Maven Biotechnologies develops label free internal reflection ellipsometry analysis systems for microplates and slide disposables that measure molecular binding in real-time on microarrays spotted in wells or on slides. It offers Polaron, a platform for developing and performing immunoassays, rapid diagnostic screening, cell-based screening, drug-target kinetics, and protein and genomic microarrays; and LFIRE, a high density imaging system for quantitative biomarker analysis. The company serves diagnostics, pharmaceuticals, research, and industrial applications. Maven Biotechnologies, LLC was founded in 2000 and is based in Pasadena, California.

Total Funding Amount:

$1.96M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Pasadena, California, United States

Founded Date:

2000-01-01

Contact Email:

info(AT)mavenbiotech.com

Founders:

William Rassman

Number of Employees:

1-10

Last Funding Date:

2010-10-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai